デフォルト表紙
市場調査レポート
商品コード
1549443

米国の磁気共鳴画像(MRI)システム市場の評価:磁場強度別、設計別、用途別、エンドユーザー別、地域別、機会、予測(2017年~2031年)

United States Magnetic Resonance Imaging Systems Market Assessment, By Field Strength, By Design, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: | 発行: Market Xcel - Markets and Data | ページ情報: 英文 135 Pages | 納期: 3~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.67円
米国の磁気共鳴画像(MRI)システム市場の評価:磁場強度別、設計別、用途別、エンドユーザー別、地域別、機会、予測(2017年~2031年)
出版日: 2024年09月06日
発行: Market Xcel - Markets and Data
ページ情報: 英文 135 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国の磁気共鳴画像(MRI)システムの市場規模は、2023年の18億3,000万米ドルから2031年に27億8,000万米ドルに達すると予測され、予測期間の2024年~2031年にCAGRで5.38%の成長が見込まれます。

MRIシステム市場は主に、米国の急速な開発と技術革新に適した医療インフラにより、米国で優位を占めると予測されます。MRI技術の進歩により、米国だけでなく世界中でMRIシステム市場の革新が加速しています。画質と診断精度における新たな進歩には、マルチパラメトリックイメージング、高磁場MRIスキャナー、AIを活用した画像解析などが含まれます。さらに、拡散テンソル画像(DTI)と機能的磁気共鳴画像(fMRI)の組み合わせにより、脳機能と結合性を研究する新たな手段が可能となり、神経疾患の診断と治療が改善されています。このように、神経疾患を発症しやすい老年人口の増加とDTIとfMRI技術の進歩が相まって、MRIシステム市場の成長をさらに促進すると予測されます。

さらに、ポータブルでコンパクトなMRIシステムの進歩により、遠隔地におけるこれらのシステムへのアクセスや利用可能性が向上しています。Fujifilm Holdings Corporationなどの世界的リーダー企業や、Hyperfine, Inc.、neuro42, Inc.などの新興市場企業は、コンパクトMRIシステムの開発に継続的に注力しています。そのため、技術の進歩や新製品の発売が米国MRIシステム市場の成長を促進します。例えば、neuro42, Inc.は2024年2月、ニューロイメージング用途向けのポータブル診断用MRIスキャナーで米国FDAの510(k)クリアランスを取得しました。同社はこのシステムを2024年中に米国市場で発売する予定です。

MRIの認知度向上が市場成長を促進

米国の磁気共鳴画像(MRI)システム市場は、MRI機器の設置台数の増加により拡大しています。高齢化、慢性疾患の増加、正確でタイムリーな診断の必要性から、先進の画像診断に対する需要が高まっているため、医療施設はMRI技術に多額の投資を行っています。スキャン時間の高速化や画像の高解像度化など、最新のMRI機器のアップグレードされた機能は、医療施設や診断センターを旧式技術からの置き換えへと引き寄せています。このような発展により、MRIサービスはより広く利用でき、価格もリーズナブルになり、より広範な疾患の治療と患者の治療成績の向上に寄与しています。さらに、非侵襲性の診断方法に対する需要の高まりや、疾患の早期診断におけるMRIの利点に関する知識の増加により、MRIシステム市場は拡大しています。例えば、南カリフォルニア大学の研究者が2023年4月に実施し、MDPI(Multidisciplinary Digital Publishing Institute)ジャーナルに掲載された研究によると、外来患者の多くの画像診断モダリティで遅延が見られ、マンモグラフィ、MRI、CTのモダリティでは1万2,000件以上の画像診断遅延が発生し、最大の減少を示しました。MRIサービスの急激な減少により、COVID-19パンデミックは市場に大きな影響を及ぼし、それ以来隆盛を極めています。

老年人口の増加が市場の成長を後押し

米国のMRIシステム市場の主な成長促進要因の1つは高齢化です。神経疾患、関節疾患、心血管疾患など、加齢に伴う健康問題の有病率は、老年人口の増加とともに上昇しています。包括的かつ非侵襲性の画像診断が可能なMRI技術は、多くの複雑な疾患の診断と治療に不可欠なツールです。老年人口は慢性疾患を抱えやすく、継続的なケアが必要なため、頻繁に画像診断が必要になる可能性が高いです。そのため、高齢化が進むにつれて先進の診断機器に対する需要が高まり、米国のMRIシステム市場の成長を促進しています。米国における65歳以上の人口構成比は、2022年の17%から2050年に23%に上昇すると予測されています。さらに、65歳以上の高齢者数は2022年の5,000万人から2050年に8,200万人に増加し、47%の増加が見込まれます。

当レポートでは、米国の磁気共鳴画像(MRI)システム市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 米国の磁気共鳴画像(MRI)システム市場の見通し(2017年~2031年)

  • 市場規模の分析と予測
    • 金額
    • 数量
  • 市場シェア分析と予測
    • 磁場強度別
    • 設計別
    • 用途別
    • エンドユーザー別
    • 地域別
    • 市場シェア分析:企業別(金額)(上位5社とその他 - 2023年)
  • 市場マップ分析(2023年)
    • 磁場強度別
    • 設計別
    • 用途別
    • エンドユーザー別
    • 地域別

第5章 需給分析

第6章 輸入と輸出の分析

第7章 バリューチェーン分析

第8章 ポーターのファイブフォース分析

第9章 PESTLE分析

第10章 価格分析

第11章 市場力学

  • 市場促進要因
  • 市場の課題

第12章 市場の動向と発展

第13章 規制枠組みとイノベーション

  • 規制当局の承認

第14章 特許情勢

第15章 ケーススタディ

第16章 競合情勢

  • マーケットリーダー上位5社の競合マトリクス
  • 上位5社のSWOT分析
  • 主要企業上位10社の情勢
    • GE Healthcare Technologies Inc.
    • Canon Medical Systems Corporation
    • Koninklijke Philips N.V.
    • Siemens Healthineers AG
    • Aurora Healthcare US Corp.
    • Fujifilm Holdings Corporation
    • Neusoft Medical Systems Co. Ltd.
    • Bruker Corporation
    • United Imaging Healthcare Co., Ltd.
    • Fonar Corporation

第17章 戦略的推奨

第18章 当社について、免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. United States Magnetic Resonance Imaging Systems Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. United States Magnetic Resonance Imaging Systems Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. United States Magnetic Resonance Imaging Systems Market Share (%), By Field Strength, 2017-2031F
  • Figure 4. United States Magnetic Resonance Imaging Systems Market Share (%), By Design, 2017-2031F
  • Figure 5. United States Magnetic Resonance Imaging Systems Market Share (%), By Application, 2017-2031F
  • Figure 6. United States Magnetic Resonance Imaging Systems Market Share (%), By End-user, 2017-2031F
  • Figure 7. United States Magnetic Resonance Imaging Systems Market Share (%), By Region, 2017-2031F
  • Figure 8. By Field Strength Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 9. By Design Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 10. By Application Size Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 11. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 12. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
目次
Product Code: MX11874

United States magnetic resonance imaging (MRI) systems market is projected to witness a CAGR of 5.38% during the forecast period 2024-2031, growing from USD 1.83 billion in 2023 to USD 2.78 billion in 2031.

The MRI systems market is expected to dominate in the United States mainly because of its fast-paced development and innovation-friendly healthcare infrastructure. Innovation in the MRI systems market has accelerated in the United States as well as globally due to advancements in MRI technologies. New advancements in image quality and diagnostic precision include multi-parametric imaging, higher-field MRI scanners, and AI-driven image analysis. In addition, new avenues for studying brain function and connectivity have been made possible by the combination of diffusion tensor imaging (DTI) and functional magnetic resonance imaging (fMRI), which has improved neurological disease diagnosis and treatment. Thus, the rising geriatric population, which is more prone to developing neurological disorders coupled with advancements in DTI and fMRI technologies, is expected further to fuel the growth of MRI systems in the market.

Furthermore, advancements in portable and compact MRI systems have improved the access and availability of these systems in remote areas. Global leaders, such as Fujifilm Holdings Corporation, and emerging market players, such as Hyperfine, Inc., and neuro42, Inc., continuously focus on developing compact MRI systems. Thus, technological advancements and new product launches will accelerate the growth of the United States MRI systems market. For instance, in February 2024, neuro42, Inc. received US FDA 510(k) clearance for its portable diagnostic MRI scanner for neuroimaging applications. The company is planning to launch this system in the US market during year 2024.

Rising Awareness About MRIs Drive Market Growth

The magnetic resonance imaging (MRI) systems market in the United States is expanding due to the growing installation of MRI machines. Healthcare facilities are heavily investing in MRI technology as demand for advanced diagnostic imaging is rising due to an aging population, an increase in chronic diseases, and the need for accurate and timely diagnosis. The upgraded features of contemporary MRI machines, such as faster scanning periods and higher resolution images, are drawing medical facilities and diagnostic centers to replace their outdated technology. These developments make MRI services more widely available and reasonably priced, treating a wider spectrum of illnesses and enhancing patient outcomes. In addition, the MRI systems market is expanding due to rising demand for non-invasive diagnostic methods and growing knowledge of the advantages of MRI in early disease diagnosis. For example, a study conducted in April 2023 and published in the Multidisciplinary Digital Publishing Institute (MDPI) journal by researchers at the University of Southern California found that delays were observed in many imaging modalities in the outpatient setting, with the modalities of mammography, MRI, and CT showing the largest decreases with over 12,000 imaging delays. Due to the sharp decline in MRI services, the COVID-19 pandemic thus had a major effect on the market and has only flourished ever since then.

Rising Geriatric Population Boosts Market Growth

One major factor propelling the growth of the MRI systems market in the United States is the aging population. The prevalence of age-related health concerns, including neurological illnesses, joint problems, and cardiovascular conditions, is rising along with the elderly population. With its comprehensive and non-invasive imaging capabilities, MRI technology is a vital tool in the diagnosis and treatment of many intricate disorders. Since they are more likely to have chronic illnesses and need ongoing care, older persons are more likely to need frequent diagnostic imaging. Thus, in turn, the aging population is driving an increased demand for advanced diagnostic instruments, which is driving the growth of the MRI systems market in the United States. The population share of the United States, which constitutes people aged 65 and above, is projected to rise from 17% in 2022 to 23% by 2050. Moreover, the number of people aged 65 and above is expected to rise from 50 million in 2022 to 82 million in 2050, showcasing a hike of 47%.

Dominance of High Field Strength MRI Segment in the United State MRI Systems Market

The magnetic resonance imaging (MRI) systems market in the United States is expanding at a substantial rate due to the introduction of high-field strength (HF) and ultra-high field strength (UH) MRI systems. Compared to conventional 1.5T MRI machines, HF MRI systems, which commonly operate at 3 Tesla (T), and UH MRI systems, which operate at 7T and beyond, offer improved imaging capabilities. These cutting-edge devices enable earlier and more accurate diagnosis of a variety of illnesses by improving image contrast, resolution, and detail. Since high-field strength MRI systems can record fine anatomical and physiological features, which are essential for diagnosing complicated neurological, musculoskeletal, and cardiovascular problems, they are gaining increasing traction and widespread adoption. For instance, in March 2024, Siemens Healthineers AG announced the launch of MAGNETOM Terra.X. This second-generation clinical 7-tesla magnetic resonance imaging scanner significantly improves 7T MR scanning capabilities with new hardware and XA60A software, which has also received FDA certification. The MAGNETOM Terra, which made its debut in 2017 as the first 7T clinical MR scanner in the world and allowed incredibly high-resolution imaging, is now replaced by the MAGNETOM Terra.X.

Neurology Segment Dominates United States Magnetic Resonance Imaging (MRI) Systems Market

MRI systems are utilized to obtain fine-grained images of the bones, organs, tissues, and nerves in the body. MRI is used to diagnose several conditions, including stroke, traumatic brain injury, brain and spinal cord tumors, inflammation, infection, vascular abnormalities, brain damage connected to epilepsy, abnormally formed brain regions, and other neurodegenerative illnesses. Due to the growing use of MRI imaging in the diagnosis of neurological diseases and the development of sophisticated MRI equipment for neurology, the neurology segment of the market is anticipated to rise significantly. Additionally, it is anticipated that the rise in neurological conditions like dementia and Alzheimer's disease will increase demand for MRI machines in the US, which will support the market's expansion throughout the projected period. For instance, the Alzheimer's Disease Facts and Figures study estimated that 6.7 million Americans, 65 years of age and older, were diagnosed with Alzheimer's dementia in 2023. Furthermore, it is anticipated that by 2050, 12.7 million of the population would be suffering from dementia in the United States.

Future Market Scenario (2024-2031F)

The main factors contributing to the anticipated growth of the United States magnetic resonance imaging (MRI) systems market are the rising numbers of chronic ailments, the increasing prevalence of diseases, and thus, the rising requirement to conduct diagnostic tests. However, the growing need to have precision medicine to maintain a healthy population is also going to fuel the MRI Systems market growth in the future. Given that technology is advancing, cutting-edge technology in the area is expected. Players in this market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. For instance, in October 2023, Koninklijke Philips N.V. announced its collaboration with Quibim to introduce advanced AI-driven imaging software aimed at prostate cancer detection. By combining Philips' innovative AI-enhanced MR imaging software with Quibim's AI-powered image analysis software, healthcare providers can expedite and simplify prostate cancer diagnosis and care.

Key Players Landscape and Outlook

The United States MRI systems market is a consolidated market with the majority of the share held by global leaders, including GE Healthcare Technologies Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Fujifilm Holdings Corporation, and Canon Inc. These players are complying with new strategic initiatives regarding the launches of newly developed magnetic resonance imaging techniques to help researchers and to strengthen their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments, and partnerships are a few ways through which they are trying to achieve the same.

For example, in September 2023, an agreement in the field of MRI was signed by Subtle Medical, Inc., an artificial intelligence (AI)-powered image acquisition solution provider, and Bracco Imaging S.p.A., a manufacturer of diagnostic imaging components. These international collaborations were anticipated to start in the United States, where Bracco Imaging most likely uses Bracco Diagnostics Inc., a subsidiary, to distribute its line of goods and services.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. United States Magnetic Resonance Imaging (MRI) Systems Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Field Strength
      • 4.2.1.1. Low
      • 4.2.1.2. Medium
      • 4.2.1.3. High
      • 4.2.1.4. Ultra-High
    • 4.2.2. By Design
      • 4.2.2.1. Open MRI
      • 4.2.2.2. Traditional MRI
      • 4.2.2.3. Wide Bore MRI
    • 4.2.3. By Application
      • 4.2.3.1. Cardiology
      • 4.2.3.2. Oncology
      • 4.2.3.3. Neurology
      • 4.2.3.4. Musculoskeletal
      • 4.2.3.5. Orthopedic
      • 4.2.3.6. Gastroenterology
      • 4.2.3.7. Others
    • 4.2.4. By End-user
      • 4.2.4.1. Hospitals
      • 4.2.4.2. Diagnostic and Imaging Centers
      • 4.2.4.3. Ambulatory Surgical Centers
      • 4.2.4.4. Others
    • 4.2.5. By Region
      • 4.2.5.1. Northeast
      • 4.2.5.2. Midwest
      • 4.2.5.3. West
      • 4.2.5.4. South
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Field Strength
    • 4.3.2. By Design
    • 4.3.3. By Application
    • 4.3.4. By End-user
    • 4.3.5. By Region

All segments will be provided for all regions and countries covered

5. Demand Supply Analysis

6. Import and Export Analysis

7. Value Chain Analysis

8. Porter's Five Forces Analysis

9. PESTLE Analysis

10. Pricing Analysis

11. Market Dynamics

  • 11.1. Market Drivers
  • 11.2. Market Challenges

12. Market Trends and Developments

13. Regulatory Framework and Innovation

  • 13.1. Regulatory Approvals

14. Patent Landscape

15. Case Studies

16. Competitive Landscape

  • 16.1. Competition Matrix of Top 5 Market Leaders
  • 16.2. SWOT Analysis for Top 5 Players
  • 16.3. Key Players Landscape for Top 10 Market Players
    • 16.3.1. GE Healthcare Technologies Inc.
      • 16.3.1.1. Company Details
      • 16.3.1.2. Key Management Personnel
      • 16.3.1.3. Products and Services
      • 16.3.1.4. Financials (As Reported)
      • 16.3.1.5. Key Market Focus and Geographical Presence
      • 16.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 16.3.2. Canon Medical Systems Corporation
    • 16.3.3. Koninklijke Philips N.V.
    • 16.3.4. Siemens Healthineers AG
    • 16.3.5. Aurora Healthcare US Corp.
    • 16.3.6. Fujifilm Holdings Corporation
    • 16.3.7. Neusoft Medical Systems Co. Ltd.
    • 16.3.8. Bruker Corporation
    • 16.3.9. United Imaging Healthcare Co., Ltd.
    • 16.3.10. Fonar Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us and Disclaimer